Ten highlights of the 2024"Clinical Practice Guidelines for the Management of Hy-pertension in China"
10.20039/j.cnki.1007-3949.2024.12.002
- VernacularTitle:2024年《中国高血压临床实践指南》十大亮点
- Author:
Qiming DENG
1
;
Yunhong WANG
1
;
Jun CAI
1
Author Information
1. 首都医科大学附属北京安贞医院高血压中心,北京市 100029
- Publication Type:Journal Article
- Keywords:
hypertension;
guideline;
clinical issues;
clinical practice
- From:
Chinese Journal of Arteriosclerosis
2024;32(12):1020-1031
- CountryChina
- Language:Chinese
-
Abstract:
In September 2024,the"Clinical Practice Guidelines for the Management of Hypertension in China"was officially released by the Chinese Society of Cardiology,Chinese Medical Association and other academic institutions.The guideline encompasses 98 recommendations for 44 key clinical issues in the management of hypertension.This arti-cle presents a concise summary of 10 highlights of the guideline,including the scientific foundation of the guideline,the concept and definition of prehypertension,simplified risk stratification for hypertension,antihypertensive treatment initia-tion timing,antihypertensive targets for different populations,first-line antihypertensive drugs,antihypertensive programs for various clinical complications,non-drug therapies,indications for renal denervation,and screening for secondary hy-pertension,in order to help doctors better understand the guidelines,promote their implementation,and guide clinical practice.
